George K. Abruzzo
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Antifungal resistance and susceptibility, Fungal Infections and Studies, Microbial Natural Products and Biosynthesis, Fungal Biology and Applications, Carbohydrate Chemistry and Synthesis
Most-Cited Works
- → Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates(2005)427 cited
- → Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors(1997)337 cited
- → Discovery of Novel Antifungal (1,3)-β- d -Glucan Synthase Inhibitors(2000)318 cited
- → In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)(1997)312 cited
- → Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis(1997)244 cited
- → Quantitative PCR Assay To Measure Aspergillus fumigatus Burden in a Murine Model of Disseminated Aspergillosis: Demonstration of Efficacy of Caspofungin Acetate(2001)208 cited